Reviews on Recent Clinical Trials


Ludovico Abenavoli
University Magna Graecia


Become EABM
Become Reviewer

Dendritic Cell Immunotherapy for Melanoma

Volume:1   Issue: 2
Pp: 87-102
Judy C. Peng, Ranjeny Thomas and Keith Dredge
DOI: 10.2174/157488706776876517

Treatment of Relapsed Acute Myeloid Leukaemia

Volume:1   Issue: 2
Pp: 103-111
Jonathan Kell
DOI: 10.2174/157488706776876445

Clinical Studies with Targeted Toxins in Malignant Glioma

Volume:1   Issue: 2
Pp: 119-131
Nikolai G. Rainov and Ariane Soling
DOI: 10.2174/157488706776876454

Iodine-Refractory Thyroid Carcinoma

Volume:1   Issue: 2
Pp: 133-141
Apar K. Ganti and Ezra E.W. Cohen
DOI: 10.2174/157488706776876526

Towards a Gene Therapy Clinical Trial for Epidermolysis Bullosa

Volume:1   Issue: 2
Pp: 155-162
Ferrari Stefano, Pellegrini Graziella, Matsui Tatsuya, Mavilio Fulvio and De L. Michele
DOI: 10.2174/157488706776876472

Alefacept - A Drug Review

Volume:1   Issue: 2
Pp: 163-164
Hadar Lev-Tov and Suhail Hadi
DOI: 10.2174/157488706776876481

Efalizumab: A Biological Agent for the Treatment of Psoriasis

Volume:1   Issue: 2
Pp: 165-168
Sarah Hodulik and Suhail Hadi
DOI: 10.2174/157488706776876436

Review: Recent Clinical Trials in Epigenetic Therapy

Volume:1   Issue: 2
Pp: 169-182
Yasuhiro Oki and Jean-Pierre J. Issa
DOI: 10.2174/157488706776876490